Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abnormal, ACS, affiliated, affirmative, affirmed, Alabama, Allegheny, alleviate, Allied, Anderson, appeal, appetite, argued, argument, arriving, Ascending, ASCO, asthenia, attended, attorney, Avastin, baseline, Bayer, belantamab, bendamustine, bevacizumab, bifurcated, bifurcation, biometric, Bioscience, biosimilar, Birmingham, BLA, Bo, bona, cabazitaxel, California, caloric, CAM, carcinoma, Carlo, CAT, ceiling, channel, Chari, Chinese, chosen, Circuit, cisplatin, Cleveland, CMV, collateral, collateralized, colony, compassionate, complaint, condensed, conjugate, contact, contrary, contributor, corridor, County, covenant, CRPC, cut, cytochrome, dacarbazine, Dec, depth, destruction, developmentand, dialogue, died, disproportionate, distributor, docetaxel, DOD, dyspnea, EEA, Eisai, endometrium, endure, Engineering, England, entrectinib, enumerated, epirubicin, eribulin, estate, eudract, EvaluatePharma, evel, expenserelated, expert, expiry, explicitly, felezonexor, fellowship, female, fide, forecasted, foreclosure, formatted, formula, Forty, frame, freight, futuredevelopment, gemcitabine, granulocyte, Halaven, Hangul, HCR, heard, Heather, hepatic, hindsight, HRSA, hypokalemia, ICML, Idera, Ik, impute, imputed, IMWG, incorrect, inline, inpatient, insert, inseverable, insomnia, intake, intentionally, inter, interrupt, interrupted, interruption, intraperiod, iposarcoma, Janseen, Jatin, Jevtana, journalBlood, judge, justification, KaryForwardTM, Katakana, larotrectinib, legitimate, lethargy, living, load, lomustine, lowest, mafodotin, mCR, Mehdi, metrial, milestonepayment, Minister, Ministry, misrepresentation, Monte, multiagent, multidisciplinary, NCI, needy, neurotrophic, nextmilestone, NMPA, nondiscriminatory, Northern, NTRK, nurse, Oct, ofour, Ohio, overcharge, overcharging, overhead, partnership, pazopanib, PBR, penalty, pharmacy, PharmaMar, pledged, preexisting, prepay, preponderance, pretax, prevail, prime, prioritization, proactive, Professor, prompt, proper, protracted, pulmonary, pyrexia, radiotherapy, rapporteur, raw, reactivation, recalculation, recessionary, reconfirm, reconsideration, remanded, remit, remitted, renal, renamed, rental, resell, restraining, retinal, roughly, RR, RRMM, Sadowski, Se, Shah, simulation, sNDA, sporadic, statutorily, stimulating, subset, Supreme, tableting, tafasitamab, Tanya, taxonomy, Tesaro, Teva, theNew, thePI, thereunder, thirty, thrombopoietin, timetable, tisagenlecleucel, trabectedin, tract, triple, triplet, tyrosine, unabsorbed, unconfirmed, unconstitutional, unreliable, unspecified, upper, upward, Urban, VA, Vanderbilt, Venclexta, Vergot, verification, vigorously, vinorelbine, virtually, Votrient, Weexpect, Welfare, whichhave, wholesale, window, withdrew, women, XBRL, ymphoma
Removed:
absence, absolute, acalabrutinib, Acerta, adenine, Afinitor, AgainstDiffuseAggressiveLymphoma, applying, arose, arrange, assume, assumed, attribution, autoimmunity, BackboneTreatmentsof, BackboneTreatmentsofMultiple, BAD, bioavailable, brentuximab, burdensome, cancelable, CEO, compelling, Composite, de, denominated, dinucleotide, diversion, Doxil, evenly, exhausted, exportation, febrile, fifty, FileNo, follicular, genome, germinal, graph, hedge, histopathology, IkB, illiquidity, impossible, inAdvancedLiposarcoma, inclusive, incorporate, incorporating, indolent, infection, intra, Janssen, leased, licensee, mark, mitochondrial, MM, MMRF, moleculeSelectiveInhibitor, myosin, NAD, Ninlaro, nivolumab, novo, occupancy, OfferingSM, ofNuclearExport, onForm, Opdivo, orSADAL, orSTORM, OurSelinexorAgainstDiffuseAggressiveLymphoma, perfect, pleiotropic, pomalidomide, preference, proceeded, proving, ratably, reconciling, reinvestment, residual, rheumatoid, robust, salvage, scheduled, secondary, sensitivity, signaling, step, steroid, sublicense, suggesting, syncytial, synergy, thalidomide, Thalomid, theSelinexor, TheSelinexorTreatmentofRefractoryMyeloma, transformed, TreatmentofRefractoryMyeloma, universal, unproven, Vd, viewed, visit, Washington, worsening
Filing tables
Filing exhibits
Related press release
Associated KPTI transcripts
KPTI similar filings
Filing view
External links
Exhibit 21.1
Subsidiaries of Karyopharm Therapeutics Inc.
Jurisdiction of Incorporation or Organization | ||
Karyopharm Securities Corp. | Massachusetts | |
Karyopharm Europe GmbH | Germany | |
Karyopharm Therapeutics (Bermuda) Ltd. | Bermuda | |
Karyopharm Israel Ltd. | Israel |